California Cancer Reporting System Standards, Volume III

IF1242: TNM Groups Beh 3 with Insitu 88 (COC)

OWNER

CoC

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

Date of Diagnosis [NAACCR #390]

Primary Site [NAACCR #400]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3 [NAACCR# 523]

TNM Clin T [NAACCR #940]

TNM Clin N [NAACCR #950]

TNM Clin M [NAACCR #960]

TNM Clin Stage Group [NAACCR #970]

TNM Path T [NAACCR #880]

TNM Path N [NAACCR #890]

TNM Path M [NAACCR #900]

TNM Path Stage Group [NAACCR #910]

Age at Diagnosis [NAACCR #230]

CS Site-Specific Factor 10 [NAACCR #2864]

CS Site-Specific Factor25 [NAACCR #2879]

Grade [NAACCR #440]

Sex [NAACCR #220]

Type of Reporting Source [NAACCR# 500]

TABLE

AC7G2016.DBF

MESSAGE

  1. IF1242: For Primary Site [value], Histologic Type ICD-O-2 [value], and Behavior Code ICD-O-3 [value], all TNM fields must not = 88

specification

This edit is skipped if any of the following conditions are true:

  1. Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid

  2. Type of Reporting Source = 7 (Death Certificate Only)

  3. Behavior Code ICD-O-3 = 0 (benign), 1 (borderline), or 2 (in situ)

 

For following TNM Groups, if Behavior Code ICD-O-3 is 3, then TNM Clin T, TNM Clin N, TMN Clin M, TNM Clin Stage Group, TNM Path T, TNM Path N, TNM Path M, and TNM Path Stage Group must not = 88. AJCC does not consider these cases stageable for in situ, but they are stageable for invasive behavior. ("88" is allowed for TNM Clin N and TNM Path N for site/histology group 039, Gestational Trophoblastic Tumors. "88" is allowed for TNM Clin Stage Group and TNM Path Stage Group for site/histology groups 053, Carcinoma of Lacrimal Gland, and 054, Sarcoma of Orbit).

 

7. Major Salivary Glands

8. Thyroid Gland (08A-08F)

9. Mucosal Melanoma of the Head and Neck

13B. Appendix: Carcinoid

16.GIST (16A-16B)

17B. NET: Small Intestine and Ampulla of Vater

17C. NET: Colon and Rectum

18.Liver

36B. Corpus Sarcoma

36C. Corpus Adenosarcoma

37A. Ovary

39.Gestational Trophoblastic Tumors

41.Prostate

43.Kidney

47.Adrenal (47A, 47B)

51A. Melanoma of Choroid

51B. Melanoma of Iris

53.Carcinoma of the Lacrimal Gland

54.Sarcoma of the Orbit

57B. Primary Cutaneous Lymphomas

historical changes

In the SEER*Edits software, the title of this edit is: IF604.

08/2016

Per NAACCR v16, new edit added.

 

Per NAACCR v16A:

  • Corrected logic for first INLIST of primary sites for site/histology group 57A, 000-419-440 changed to 000-440.

  • Corrected logic to edit for site/histology groups 36B and 36C rather than 36A and 36B.

  • Corrected Edit Logic to include 9727 as lymphoma rather than lymphoma/leukemia code, to delete 9728-9729 as obsolete codes.

  • Added Group 57C, C420, C421, C424, 9811-9818, 9837, to Edit Logic.

11/2016

Per NAACCR v16B:

  • Corrected Description and Edit Logic for site/histology groups 053,054, edit does not fail on TNM Clin Stage Group = 88 or TNM Path Stage Group = 88 for 053,054.

  • Added check for Behavior Code ICD-O-3 for site/histology group 039.

  • Corrected edit logic for assigning site/histology group 011 to group 10B. or 999 based on histology and CS Site-Specific Factor 25.